There are currently several generic Reglan (metoclopramide) products available on the market. The generic tablets come in two strengths, while the generic oral solution is only available in one strength. Generic Reglan is also available in injectable form. A number of different drug companies manufacture these generic products, including Major Pharmaceuticals and Teva Pharmaceuticals.
Reglan® (metoclopramide) is a prescription medication used to treat gastroesophageal reflux disease (GERD) and diabetic gastroparesis. It is approved for short-term use only.
Brand-name Reglan tablets are made by ANI Pharmaceuticals, Inc. Brand-name Reglan injection is made by Baxter Healthcare Corporation. However, the patents for Reglan have expired, and it is currently available in generic form.
Generic Reglan comes in the following strengths and forms:
- Metoclopramide 5 mg tablets
- Metoclopramide 10 mg tablets
- Metoclopramide oral solution -- 5 mg per 5 mL (per teaspoonful).
Generic Reglan is also available in injectable form.
Generic metoclopramide is made by many different companies, including:
- Major Pharmaceuticals
- Mutual Pharmaceutical Company, Inc.
- Pliva, Inc.
- Teva Pharmaceuticals USA.
All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns each generic a rating. An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. All of the generic metoclopramide versions currently available have an "AB" rating, meaning they should be equivalent to Reglan.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers or dyes or other ingredients that may cause problems for people with allergies or sensitivities.